LB Pharmaceuticals, Inc. LBRX
NASDAQ · United States · Health Technology
$37.90-0.48 (-1.25%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -1.71 | -0.80 | -112.8% | $0 | — | -1.0%$45.85→$45.38 |
| Q1 2026 | 2026-05-12 | -0.67 | -0.75 | +10.7% | — | — | -1.2%$32.69→$32.31 |
| Q4 2025 | 2026-03-26 | -0.45 | -0.32 | -40.6% | — | — | -1.5%$24.21→$23.84 |
| Q3 2025 | 2025-11-06 | -0.61 | -0.57 | -7.0% | — | — | -5.2%$16.20→$15.35 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.